CORD-19:ee0a7632371a08727d41e55aad7d621daeceef7d / 64274-64493 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T74079","span":{"begin":0,"end":219},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The study included 9 healthy donors of bone marrow stem cells (controls) and 21 pared samples (bone marrow and peripheral blood) of patients with diagnosis of myeloproliferative neoplasia according to WHO 2014 criteria."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T160","span":{"begin":0,"end":219},"obj":"Sentence"}],"text":"The study included 9 healthy donors of bone marrow stem cells (controls) and 21 pared samples (bone marrow and peripheral blood) of patients with diagnosis of myeloproliferative neoplasia according to WHO 2014 criteria."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T108","span":{"begin":178,"end":187},"obj":"Phenotype"}],"attributes":[{"id":"A108","pred":"hp_id","subj":"T108","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"The study included 9 healthy donors of bone marrow stem cells (controls) and 21 pared samples (bone marrow and peripheral blood) of patients with diagnosis of myeloproliferative neoplasia according to WHO 2014 criteria."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T51","span":{"begin":39,"end":50},"obj":"Body_part"},{"id":"T52","span":{"begin":95,"end":106},"obj":"Body_part"},{"id":"T53","span":{"begin":122,"end":127},"obj":"Body_part"}],"attributes":[{"id":"A51","pred":"uberon_id","subj":"T51","obj":"http://purl.obolibrary.org/obo/UBERON_0002371"},{"id":"A52","pred":"uberon_id","subj":"T52","obj":"http://purl.obolibrary.org/obo/UBERON_0002371"},{"id":"A53","pred":"uberon_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"The study included 9 healthy donors of bone marrow stem cells (controls) and 21 pared samples (bone marrow and peripheral blood) of patients with diagnosis of myeloproliferative neoplasia according to WHO 2014 criteria."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T297","span":{"begin":178,"end":187},"obj":"Disease"},{"id":"T36860","span":{"begin":178,"end":187},"obj":"Disease"}],"attributes":[{"id":"A297","pred":"mondo_id","subj":"T297","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"},{"id":"A39511","pred":"mondo_id","subj":"T36860","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"}],"text":"The study included 9 healthy donors of bone marrow stem cells (controls) and 21 pared samples (bone marrow and peripheral blood) of patients with diagnosis of myeloproliferative neoplasia according to WHO 2014 criteria."}